Blast Counts Not Enough to Distinguish MDS From AML, Experts Say

Oncologists argue that in differentiating myelodysplastic syndrome from acute myeloid leukemia, more than just bone marrow blast cutoff should be considered.
Medscape Medical News

source https://www.medscape.com/viewarticle/968413?src=rss

Comments

Popular posts from this blog

DC’s Harllee Harper Is Using Public Health Tools to Prevent Gun Violence. Will It Work?